Oncology

News

Lonza builds its ADC capacity with Synaffix takeover

Lonza has boosted its ability to cater for customers in the fast-emerging antibody-drug conjugate category with a deal to buy Dutch company Synaffix and its platform techn

R&D

ASCO 2023 preview: Prioritising the exploration of patient d...

The American Society of Clinical Oncology (ASCO) annual meeting is approaching and provides the ideal setting to connect

News

SNIPR shoots down resistant E. coli in first human trial

SNIPR Biome has said its CRISPR therapeutic targeting a problem bacterial pathogen has shown proof-of-concept in a phase 1 trial, raising hopes of a new way to treat resis

Oncology

How to optimise delivery of patient support programs in cancer

How to optimise delivery of patient support programmes in ca...

Patient support programmes (PSPs) hold great promise for oncology patients, healthcare professionals, and pharma companies by bridging the gap between clinic and home care.

News

Boundless Bio raises $100m for circular DNA cancer therapy

Boundless Bio’s plans to develop a new class of cancer therapies targeting DNA found outside the nucleus of malignant cells have been boosted by a $100 million fundraising

News

And Astellas’ latest drug discovery partner is… Sony?

Astellas Pharma has looked outside of the box for its latest cancer drug development partnership, joining forces with Sony on a project to find new antibody-drug conjugate

Lonza builds its ADC capacity with Synaffix takeover

ASCO 2023 preview: Prioritising the exploration of patient d...

SNIPR shoots down resistant E. coli in first human trial

How to optimise delivery of patient support programmes in ca...

Boundless Bio raises $100m for circular DNA cancer therapy

And Astellas’ latest drug discovery partner is… Sony?

Treating the chronic diseases GLP-1s miss, with Laurent Auda...

How to meet your physicians where they are online

Oncology

Editor's Picks